<DOC>
	<DOCNO>NCT00122616</DOCNO>
	<brief_summary>The aim study prove efficacy peginterferon HIV infect patient liver disease cause hepatitis C virus ( HCV ) treatment eradicate virus fail . This scientific proof need comparative study do include two group patient randomly allocate : one treatment ( peginterferon ) without treatment HCV duration 2 year . To conclude , two liver biopsy need ; one study second 2 year .</brief_summary>
	<brief_title>Efficacy Pegylated Interferon Liver Fibrosis Co-infected Patient With HIV Hepatitis C</brief_title>
	<detailed_description>C hepatitis HIV infect patient becomes major issue although survival patient , improve last decade regard advent HAART , mortality relate liver disease increase population . Sustained virological response HCV obtain peg-interferon ribavirin treatment le 50 % patient experienced failure treatment liver fibrosis due HCV infection progress may lead cirrhosis hepato-carcinoma . To demonstrate efficacy peginterferon therapy reduce liver damage cause HCV infection , randomise control study need compare one group patient treat peginterferon one group without treatment HCV infection . In order show 30 % difference two group reduce one point fibrosis score ( METAVIR scale ) , 150 patient need . The duration study 96 week</detailed_description>
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis A</mesh_term>
	<mesh_term>Hepatitis C</mesh_term>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Hepatitis C , Chronic</mesh_term>
	<mesh_term>Liver Cirrhosis</mesh_term>
	<mesh_term>Interferons</mesh_term>
	<mesh_term>Ribavirin</mesh_term>
	<mesh_term>Peginterferon alfa-2a</mesh_term>
	<mesh_term>Interferon-alpha</mesh_term>
	<criteria>HIV infection ( Western Blot + ) C hepatitis ( RNA viral hepatitis C [ VHC ] + ) Chronic active C hepatitis liver histological score METAVIR ( A equal 1 F equal 2 ) biopsy perform least 18 month expect date inclusion Previous treatment C hepatitis least 3 month include peginterferon ribavirin peginterferon alone counterindication ribavirin occur Failure eradicate C hepatitis virus well conduct treatment The liver biopsy realise least 18 month inclusion : Either treatment C hepatitis patient treat 7 month Or least 6 month anti HCV treatment patient treat 7 month ( wash period ) Regular follow outpatient clinic HIV Unchanged antiretroviral treatment last 3 month inclusion Inform consent History transplantation clinical hepatic failure Opportunistic infection past three month inclusion Any hepatic disease relate HCV ( B hepatitis , hemochromatosis , Wilson disease ) Diabetes mellitus Immunocompromised treatment Active intravenous drug addiction Alcohol consumption 50 g per day Counterindication use interferon</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2012</verification_date>
	<keyword>HIV infection</keyword>
	<keyword>peginterferon alfa-2a</keyword>
	<keyword>Treatment Failure</keyword>
	<keyword>Hepatitis C , Chronic</keyword>
	<keyword>Treatment Experienced</keyword>
</DOC>